Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment

Autor: Eikeland, Siri Asheim, Smeland, Knut Bjøro, Simensen, Victoria C, Fagerli, Unn Merete, Bersvendsen, Hanne Skjerven, Kiserud, Cecilie E., Fosså, Alexander

Publikováno v: Eikeland, Siri Asheim Smeland, Knut Bjøro Simensen, Victoria C Fagerli, Unn Merete Bersvendsen, Hanne Skjerven Kiserud, Cecilie E. Fosså, Alexander . Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment. Acta Oncologica. 2023
Acta Oncologica

Externí odkaz: http://hdl.handle.net/10852/101987

Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects

Autor: Dahl, Alv A, Smeland, Knut Bjøro, Eikeland, Siri Asheim, Fagerli, Unn Merete, Bersvendsen, Hanne Skjerven, Fosså, Alexander, Kiserud, Cecilie E.

Publikováno v: Dahl, Alv A Smeland, Knut Bjøro Eikeland, Siri Asheim Fagerli, Unn Merete Bersvendsen, Hanne Skjerven Fosså, Alexander Kiserud, Cecilie E. . Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects. Jo
Jo

Externí odkaz: http://hdl.handle.net/10852/108649

Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

Autor: Smeland, Knut Bjøro, Holte, Harald, Fagerli, Unn-Merete, Bersvendsen, Hanne Skjerven, Hjermstad, Marianne Jensen, Loge, Jon Håvard, Murbræch, Klaus, Linnsund, Marianne Dahl, Fluge, Øystein, Stenehjem, Jo Steinson, Samersaw-Lund, May Brit, Kvaløy, Stein Olav, Kiserud, Cecilie E.

Externí odkaz: https://hdl.handle.net/11250/3047169

Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life

Autor: Eikeland, Siri A., Smeland, Knut Bjøro, Mols, Floortje, Fagerli, Unn-Merete, Bersvendsen, Hanne Skjerven, Kiserud, Cecilie E., Fosså, Alexander

Externí odkaz: https://hdl.handle.net/11250/2983736

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

Autor: Jakobsen, Lasse Hjort, Ellin, Fredrik, Smeland, Knut Bjøro, Wästerlid, Tove, Christensen, Jacob Haaber, Jørgensen, Judit Mészáros, Josefsson, Pär Lars, Øvlisen, Andreas K., Holte, Harald, Blaker, Yngvild Nuvin, Grauslund, Jacob Handlos, Bjørn, Jon, Molin, Daniel, Lagerlöf, Ingemar, Smedby, Karin Ekström, Colvin, Katherine, Thanarajasingam, Gita, Maurer, Matthew J., Habermann, Thomas Matthew, Song, Kevin W., Song, Katie Y., Gerrie, Alina S., Cheah, Chan Yoon, El-Galaly, Tarec Christoffer

Publikováno v: Jakobsen, Lasse Hjort Ellin, Fredrik Smeland, Knut Bjøro Wästerlid, Tove Christensen, Jacob Haaber Jørgensen, Judit Mészáros Josefsson, Pär Lars Øvlisen, Andreas K. Holte, Harald Blaker, Yngvild Nuvin Grauslund, Jacob Handlos Bjørn, Jon Molin, Daniel Lagerlöf, Ingemar Smedby, Karin Ekström Colvin, Katherine Thanarajasingam, Gita Maurer, Matthew J. Habermann, Thomas Matthew Song, Kevin W. Song, Katie Y. Gerrie, Alina S. Cheah, Chan Yoon El-Galaly, Tarec Christoffer . Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients. British Jo
British Jo

Externí odkaz: http://hdl.handle.net/10852/82835
https://www.duo.uio.no/bitstream/handle/10852/82835/1/Postnr%2B1814137_Jakobsen_Holte_Blaker_Br%2BJ%2BHaematol%2B2020.pdf